Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Wix.Com Ltd — how do they compare? Vertex Pharmaceuticals Incorporated trades at $528.01 (market cap $132.79B), while Wix.Com Ltd trades at $66.44 (market cap $2.61B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 50.9× Wix.Com Ltd's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| VRTX | WIX | |
|---|---|---|
Market Cap | $132.79B | $2.61B |
Sector | Health | Technology |
52-Week High | $529.65 | $184.24 |
52-Week Low | $376.62 | $40.43 |
Enterprise Value | $126.92B | $3.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertex Pharmaceuticals (VRTX) trades at $496.07, up 2.49% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported Q2 2026 revenue of $3.3 billion, beating estimates, and raised its full-year sales outlook, driven by cystic fibrosis treatments and newer products like CASGEVY. Financials show robust profitability with a 35% net income margin and positive cash flow trends, though recent EPS results have been mixed.
Outlook remains positive with an 84% analyst buy rating and a $534.25 consensus price target, implying upside. Key risks include execution on new product launches and competitive pressures, but solid fundamentals and raised guidance support a constructive view for investors seeking growth in biopharma.
Wix trades at $60.20, down 1.12% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $79.75 suggesting significant upside. Revenue grew to $1.99 billion in 2025, though net income margin remains negative at -8.19%. Recent earnings show three beats and one miss in the last four quarters, with a notable 27% price drop following the Q1 2026 miss.
The outlook is mixed: strong revenue growth and analyst optimism contrast with profitability challenges and a securities class action lawsuit alleging misleading statements. The stock offers potential for appreciation if execution improves, but faces near-term legal and operational risks that could pressure the share price.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
